UNSPSC 51111735: Cemadotin

This classification denotes a vinca-site binding agent with the molecular formula C35H56N6O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6SQ8M7ZSFV, chemically known as l-prolinamide, n,n-dimethyl-l-valyl-l-valyl-n-methyl-l-valyl-l-prolyl-n-(phenylmethyl)- but generally known as cemadotin, which bears US NIH Compound Identifier 178028. European Medicines Agency schedules Cemadotin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07438MIG.

UNSPSC 51111735 Cemadotin, a Commodity code, does not map to the state and local procurement activity recently tagged under it. The recent opportunities show no purchasing of cemadotin, a pharmaceutical compound used in oncology treatment; instead, the code carries posts for naloxone and drug deactivation systems, generic multi-source pharmaceuticals and OTC products, and medical and first aid supplies for emergency response. State and local governments are using this code tag to solicit pharmaceutical products, medical supplies, and public-health-related consumables, but the tagged opportunities do not reflect the code's nominal scope. The issuing bodies include county health departments, state HHS commissions, municipal fire departments, and multistate cooperative purchasing alliances, spanning health systems, emergency response, and pharmacy benefit programs.

Recent activity appears in Florida, Texas, and Minnesota. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the Texas Health and Human Services Commission posted an RFI on April 3, 2026 seeking vendor capabilities for direct-to-manufacturer prescription programs; the City of Tampa posted an IFB on March 25, 2026 (due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, a $700,000 procurement sheltered for certified Small Local Business Enterprises with a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance posted an RFP on January 20, 2026 (due March 26, 2026) to establish contracts for generic pharmaceuticals and OTC products through authorized wholesalers. The code shows little relevant recent activity aligned with its nominal pharmaceutical scope.